Citius Pharmaceuticals, Inc.

CIK 0001506251 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols

CTXR on Nasdaq

Ownership signals CIK-linked ownership evidence from parsed SEC filings. 1 signal

Parsed SEC ownership signals

Largest active 13D stakes

Active large-stake positions disclosed in parsed Schedule 13D filings.

CTOR

How to read these SEC ownership signals

• Read each filing family separately: Form 13F, Schedules 13D/G, and Forms 3/4/5 answer different SEC disclosure questions and should not be blended into one ownership total.
• Use 13F values for visible U.S.-listed equity portfolios, 13D/G rows for large beneficial-owner stakes, and Forms 3/4/5 rows for reporting-owner positions and transactions.
• Open the linked research path when you need the filing, CIK, issuer, CUSIP, date, or source trail behind a value.

At a glance Names, identifiers, and filing context for this profile. 2 identity fields

SEC industry group

Pharmaceutical Preparations (Office of Life Sciences)

Business address

11 Commerce Drive, 1 St Floor, Cranford, NJ, 07016

EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available

Incorporated in

NV

Fiscal year end

30 September

Former names on EDGAR

Trail One, Inc. (to 18 Sep 2014), TrailOne, Inc. (to 21 Jan 2011)